HCPCS Level II · Drugs administered other than oral method
J2002Injection, lidocaine hcl in 5% dextrose, 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2002
J2002 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, lidocaine hcl in 5% dextrose, 1 mg.
It was added to HCPCS effective 10/01/2024, and its current record took effect 01/01/2025.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, lidocaine in d5w, 1 mg
- Date added
- 10/01/2024
- Action effective
- 01/01/2025
- BETOS
- O1E
Related J20xx codes
- J2003Injection, lidocaine hydrochloride, 1 mg
- J2004Injection, lidocaine hcl with epinephrine, 1 mg
- J2010Injection, lincomycin hcl, up to 300 mg
- J2020Injection, linezolid, 200 mg
- J2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
- J2060Injection, lorazepam, 2 mg
- J2062Loxapine for inhalation, 1 mg
Common questions about J2002
Is HCPCS J2002 still valid?
- Yes. J2002 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J2002?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.